CD73/A2AR dual pharmacological targeting for early therapeutic intervention in multiple sclerosis
A therapeutic approach targeting the adenosine-producing enzyme CD73 and the A2A adenosine receptor simultaneously to strengthen the blood-CSF barrier at the choroid plexus. This dual intervention aims to delay or preven...